Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Infectious disease: Zoonosis
  • Remove this filter Infectious disease: Vaccine preventable diseases
  • Remove this filter Infectious disease: Influenza in humans, avian origin
  • Remove this filter Infectious disease: Zoonotic influenza
  • Remove this filter Infectious disease: Influenza A (H9N2)
  • Remove this filter Type: Expert opinion
  • Remove this filter Public health area: Prevention and control
  • Remove this filter Public health area: Disease prevention
  • Remove this filter Public health area: Prophylaxis
  • Infectious disease
    • Zoonosis (1)
    • Vaccine preventable diseases (1)
    • Influenza in humans, avian origin (1)
    • Zoonotic influenza (1)
    • Influenza A (H9N2) (1)
    • Respiratory diseases (1)
    • Influenza (1)
    • Influenza in humans, seasonal (1)
    • Influenza in humans, swine origin (1)
    • Avian influenza virus (1)
    • Seasonal influenza (1)
    • Flu (1)
    • Avian influenza in humans (1)
  • Public health area
    • Prevention and control (1)
    • Disease prevention (1)
    • Prophylaxis (1)
    • Scientific advice (1)
    • Antiviral (1)
  • Country
    • Europe (1)
  • Media type
    • Expert opinion (1)
    • Publication (1)
  • Page 1 of 1 // 1 Results found
    • Sort by:

Publication

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

Expert opinion - 14 Aug 2017

This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - EN - [PDF-1.15 MB]
  • Antiviral
  • Avian influenza virus
  • Europe
  • Influenza
  • Influenza in humans, avian origin
  • Influenza in humans, seasonal
  • Prevention and control
  • Scientific advice
  • Zoonotic influenza
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us